Please use this identifier to cite or link to this item:
Title: MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice
Author: Santos García, Diego
Álvarez Sauco, Maria
Calopa, Matilde
Carrillo, Fátima
Escamilla Sevilla, Francisco
Freire, Eric
García Ramos, R.
Kulisevsky, Jaime
Gómez Esteban, Juan Carlos
Legarda, Inés
Luquín, María Rosario Isabel
Castrillo, Juan Carlos Martínez
Martínez Martin, Pablo
Martínez Torres, Irene
Mir, Pablo
Ignacio, Ángel Sesar
Keywords: Malaltia de Parkinson
Manifestacions neurològiques de les malalties
Parkinson's disease
Neurologic manifestations of general diseases
Issue Date: 28-Dec-2021
Publisher: MDPI AG
Abstract: Background and objective: Parkinson's disease (PD) is a clinically heterogeneous disorder in which the symptoms and prognosis can be very different among patients. We propose a new simple classification to identify key symptoms and staging in PD. Patients and Methods: Sixteen movement disorders specialists from Spain participated in this project. The classification was consensually approved after a discussion and review process from June to October 2021. The TNM classification and the National Institutes of Health Stroke Scale (NIHSS) were considered as models in the design. Results: The classification was named MNCD and included 4 major axes: (1) motor symptoms; (2) non-motor symptoms; (3) cognition; (4) dependency for activities of daily living (ADL). Motor axis included 4 sub-axes: (1) motor fluctuations; (2) dyskinesia; (3) axial symptoms; (4) tremor. Four other sub-axes were included in the non-motor axis: (1) neuropsychiatric symptoms; (2) autonomic dysfunction; (3) sleep disturbances and fatigue; (4) pain and sensory disorders. According to the MNCD, 5 stages were considered, from stage 1 (no disabling motor or non-motor symptoms with normal cognition and independency for ADL) to 5 (dementia and dependency for basic ADL). Conclusions: A new simple classification of PD is proposed. The MNCD classification includes 4 major axes and 5 stages to identify key symptoms and monitor the evolution of the disease in patients with PD. It is necessary to apply this proof of concept in a properly designed study.
Note: Reproducció del document publicat a:
It is part of: Diagnostics, 2021, vol 12, num 1
Related resource:
ISSN: 2075-4418
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
diagnostics-12-00055.pdf3.03 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons